Public Funds Majority Of Medicines R&D, Must Hold Drug Companies Accountable

Thomson Reuters Foundation: Equality, Big Pharma and lifesaving medicine
John Butler, a consultant and global public health expert, and Brian Wahl, a doctoral student studying epidemiology and disease control at Johns Hopkins Bloomberg School of Public Health

“…Governments and civil society must again unite behind the simple idea that everyone has the right to health. That is, medicines must be affordable and accessible for all. With money for research and development coming largely from public sources, we must all hold pharmaceutical companies accountable and demand they serve people first…” (2/4).